Literature DB >> 2193850

Autoantibodies to retinal astrocytes associated with age-related macular degeneration.

P L Penfold1, J M Provis, J H Furby, P A Gatenby, F A Billson.   

Abstract

Sera from 128 patients with age-related macular degeneration (AMD) were examined and profiles of a variety of serum constituents, including immunoglobulins, alpha and beta globulins and autoantibodies, were tabulated. A similar series of tests were carried out on 20 control sera. The results indicate a higher incidence of serum abnormalities, particularly involving alpha-2 globulin, in patients with disturbance of pigmentation of the retinal pigment epithelium (RPE). The sera were further tested for the presence of autoantibodies with specificity for retinal tissue, and five major staining patterns were observed. Many sera produced patterns of labelling on human retina identical to that observed using labelled monoclonal anti-glial fibrillary acid protein (GFAP) antibodies, which are an established marker of retinal astrocytes. Although anti-retinal autoantibodies have been reported in association with a number of ocular pathologies, the observation of anti-astrocyte autoantibodies is new. Astrocytes are involved in the maintenance of the blood-retinal barrier (BRB) and also appear to be the facultative antigen-presenting cells of neural tissue. The present results indicate that the formation of anti-astrocyte autoantibodies may be an early feature of the pathogenesis of AMD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193850     DOI: 10.1007/bf00920033

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Risk factors in age-related maculopathy complicated by choroidal neovascularization.

Authors:  M S Blumenkranz; S R Russell; M G Robey; R Kott-Blumenkranz; N Penneys
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

2.  Montgomery lecture. Subretinal neovascularisation in senile macular degeneration.

Authors:  G Coscas
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

3.  Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium.

Authors:  P L Penfold; M C Killingsworth; S H Sarks
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-03       Impact factor: 4.799

4.  The intermediate filament complement of the retina: a comparison between different mammalian species.

Authors:  G Shaw; K Weber
Journal:  Eur J Cell Biol       Date:  1984-01       Impact factor: 4.492

5.  Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings.

Authors:  J R Heckenlively; A M Solish; S M Chant; R H Meyers-Elliott
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

6.  Relationship between astrocytes, ganglion cells and vasculature of the retina.

Authors:  J Stone; Z Dreher
Journal:  J Comp Neurol       Date:  1987-01-01       Impact factor: 3.215

Review 7.  Senile macular degeneration: review of epidemiologic features.

Authors:  F L Ferris
Journal:  Am J Epidemiol       Date:  1983-08       Impact factor: 4.897

8.  Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis.

Authors:  D C Dumonde; E Kasp-Grochowska; E Graham; M D Sanders; J P Faure; Y de Kozak; V van Tuyen
Journal:  Lancet       Date:  1982-10-09       Impact factor: 79.321

Review 9.  Age-related macular degeneration.

Authors:  N M Bressler; S B Bressler; S L Fine
Journal:  Surv Ophthalmol       Date:  1988 May-Jun       Impact factor: 6.048

10.  Autoimmunity in hereditary retinal degeneration. I. Basic studies.

Authors:  S M Chant; J Heckenlively; R H Meyers-Elliott
Journal:  Br J Ophthalmol       Date:  1985-01       Impact factor: 4.638

View more
  36 in total

Review 1.  Keypathophysiologic pathways in age-related macular disease.

Authors:  Felix Roth; Almut Bindewald; Frank G Holz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

2.  Serum levels of antioxidants and age-related macular degeneration.

Authors:  N C Tsang; P L Penfold; P J Snitch; F Billson
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 4.  Age-related macular degeneration and the immune response: implications for therapy.

Authors:  Robert B Nussenblatt; Frederick Ferris
Journal:  Am J Ophthalmol       Date:  2007-08-15       Impact factor: 5.258

5.  Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations.

Authors:  J R Heckenlively; N Aptsiauri; S Nusinowitz; C Peng; P A Hargrave
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 6.  Inflammatory Mechanisms of Age-related Macular Degeneration.

Authors:  Jared E Knickelbein; Chi-Chao Chan; H Nida Sen; Frederick L Ferris; Robert B Nussenblatt
Journal:  Int Ophthalmol Clin       Date:  2015

7.  Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration.

Authors:  Alessandro Iannaccone; T J Hollingsworth; Diwa Koirala; David D New; Nataliya I Lenchik; Sarka Beranova-Giorgianni; Ivan C Gerling; Marko Z Radic; Francesco Giorgianni
Journal:  Exp Eye Res       Date:  2016-12-15       Impact factor: 3.467

8.  Fcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration.

Authors:  Salome Murinello; Robert F Mullins; Andrew J Lotery; V Hugh Perry; Jessica L Teeling
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-13       Impact factor: 4.799

9.  The Immune System and AMD.

Authors:  Paul A Frederick; Mark E Kleinman
Journal:  Curr Ophthalmol Rep       Date:  2014-03-01

Review 10.  Immunology of age-related macular degeneration.

Authors:  Jayakrishna Ambati; John P Atkinson; Bradley D Gelfand
Journal:  Nat Rev Immunol       Date:  2013-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.